MarketInOut Stock Screener Log In | Sign Up

Shanghai Bao Pharmaceuticals Co Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Shanghai Bao Pharmaceuticals Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization2,517.65 mln
Float17.25 mln
Earnings Date08/28/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-15.66
Highly reliable

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.29
Very low leverage

Pre-Tax Margin

-2,132%
Severely loss-making

ROE

-23.63
Deeply negative

Business Description

Shanghai Bao Pharmaceuticals is a China-based biotechnology company founded in 2019 that uses synthetic biology to create and bring to market a range of biological drug treatments. Its portfolio spans therapies for autoimmune diseases, bacterial infections, and assisted reproduction, with several products already in clinical trials and others in earlier stages of development. The company also generates revenue by licensing its intellectual property and offering technical services to partners.

Key Fundamentals

EPS-1.46
ROE-23.63
ROIC-26.04
ROA-16.37
EBITDA, mln-355
EV / EBITDA-8.99
EV / EBIT-7.98
Revenue, mln19.10
EV / Revenue167

Quote Details

Last 8.01
Change -0.42 (-4.98%)
Open 8.60
Volume 1,728,900
Turnover 13,848,489
Average Volume 853,519

Financial Ratios

Pre-Tax Profit Margin-2,132
Current Ratio3.85
Price / Book2.39
Price / Tangible Book2.41
Debt / Equity0.29
Price / Sales209

Financial Strength

Altman Z-Score2.85
Piotroski F-Score 4 / 9
Beneish M-Score-15.66

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.82% 79 / 100   
1 Month -35.14% 5 / 100   
2 Months -53.57% 3 / 100   
6 Months -89.31% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog